These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 1719097)

  • 1. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
    Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
    CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple motifs regulate the B-cell-specific promoter of the B29 gene.
    Omori SA; Wall R
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11723-7. PubMed ID: 8265616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter.
    Thévenin C; Lucas BP; Kozlow EJ; Kehrl JH
    J Biol Chem; 1993 Mar; 268(8):5949-56. PubMed ID: 7680653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
    Ying H; Chang JF; Parnes JR
    J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7.
    Wang J; Walker H; Lin Q; Jenkins N; Copeland NG; Watanabe T; Burrows PD; Cooper MD
    Genomics; 1996 Apr; 33(2):167-76. PubMed ID: 8660964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a diverged octamer binding site important in the B cell-specific expression of the CD20 gene.
    Thevenin C; Rieckmann P; Kozlow EJ; Kehrl JH
    Trans Assoc Am Physicians; 1992; 105():15-24. PubMed ID: 1285015
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of cis-acting elements present in the CD20/B1 antigen promoter.
    Rieckmann P; Wilson GL; Thevenin C; Hong JX; Kehrl JH
    J Immunol; 1991 Dec; 147(11):3994-9. PubMed ID: 1719097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient transfection assays to examine the requirement of putative cell death genes.
    Osborne BA; Smith SW; Liu ZG; McLaughlin KA; Schwartz LM
    Methods Cell Biol; 1995; 46():99-106. PubMed ID: 7541887
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.